When applied topically, the drug is practically not absorbed, so its concentration is very small (by modern analytical methods are not defined) in the blood plasma.

Indications for use:

Applied with acute respiratory propionate illness with symptoms of rhinitis (runny nose), acute allergic rhinitis, sinusitis, otitis media with (as part of combination therapy to reduce swelling of the mucous nasopharynx) to facilitate rhinoscopy.


Hypersensitivity to xylometazoline, hypertension, tachycardia, marked atherosclerosis, glaucoma, atrophic rhinitis, hyperthyroidism, surgical intervention on meninges (in history), pregnancy, lactation, children under 2 years old.

Do not use in the treatment of propionate and tricyclic antidepressants.

With care – diabetes.

Dosage and administration:

Adults and children over 6 years of age are administered 1-2 drops of 0.1% xylometazoline solution in each nostril 2-3 times a day.

Children from 2 to 6 years of use of 0.05% solution of 1-2 drops in each nostril 1-2 times a day. Do not use the drug more than 3 times a day and no more than 3-5 days. Do not use the drug without interruption for more than 3-5 days.

Side effects:

Frequent and / or long-term use – irritation and / or dryness of the nasal mucosa, burning, stinging, sneezing, hypersecretion; rare – swelling of the nasal mucosa, vomiting, headache, palpitations, increased blood pressure, insomnia, blurred vision, depression (long-term use of high doses).


Symptoms: increased side effects. Treatment: symptomatic under the supervision of a physician.

Interaction with other drugs:

Perhaps strengthening systemic effect, while the use of propionate inhibitors and tricyclic antidepressants.

Special instructions:

Before first use, plastic bottle cap screwed as possible. In this tire. which is on its inner side hole pierces. The cap is unscrewed, removed, and slightly pressing the bottle body, the solution is instilled into the nose. After opening the vial the drug pass 28 days.

Do not use the drug for a long time, for example, in chronic rhinitis.

Effects on ability to drive a vehicle or equipment:

Xylometazoline, in doses exceeding recommended, may propionate affect the ability to drive a vehicle or equipment.